Visual Outcomes Following Bilateral Implantation of a Non-diffractive Wavefront-shaping Extended Depth of Focus Toric Intraocular Lens
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cataract Senile
- Sponsor
- LEC Eye Centre
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Binocular UIVA
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.
Detailed Description
This is a prospective interventional case series of 30 patients who underwent cataract surgery and bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens. This study is represented by an Asian cohort of patients and the study evaluations were focused not only on clinical visual outcomes but also on "real-life" patient reported outcomes such as dysphotopsias, spectacle independence and daily visual tasks all of which were measured at 1 month and up to 3 months postoperatively. The objective would be to provide insight into the performance of this intraocular lens in Asian patients.
Investigators
Mun Wai Lee
Medical Director
LEC Eye Centre
Eligibility Criteria
Inclusion Criteria
- •patients aged 18 years or older
- •bilateral significant cataracts
- •bilateral significant corneal astigmatism
Exclusion Criteria
- •previous refractive surgery
- •amblyopia
- •strabismus
- •any ocular co-morbidity which could impact on final visual acuity
- •pre-existing zonular weakness
- •capsular instability or compromise
Outcomes
Primary Outcomes
Binocular UIVA
Time Frame: 3 months
Binocular Uncorrected Intermediate Visual Acuity
Binocular UDVA
Time Frame: 3 months
Binocular Uncorrected Distance Visual Acuity
Binocular UNVA
Time Frame: 3 months
Binocular Uncorrected Near Visual Acuity
Secondary Outcomes
- Rotational Stability(1 month)
- Binocular Defocus Curve(3 months)
- DCNVA(3 months)
- MRSE(3 months)
- VF-14(3 months)
- CDVA(3 months)
- DCIVA(3 months)
- Contrast Sensitivity(3 months)
- QUVID(3 months)